Nj State Employees Deferred Compensation Plan Eli Lilly & CO Transaction History

Nj State Employees Deferred Compensation Plan

$877 Million
Q3 2025

A detailed history of Nj State Employees Deferred Compensation Plan transactions in Eli Lilly & CO stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 18,210 shares of LLY stock, worth $16.8 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares

18,210

Previous 17,160 6.12%

Holding current value

$16.8 Million

Previous $13.4 Million 3.87%

% of portfolio

1.58%

Previous 1.63%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$625.65 - $812.69 $656,932 - $853,324	1,050 Added 6.12%	18,210 $13.9 Million
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $2.46 Million - $3.09 Million	-3,400 Reduced 16.54%	17,160 $15.5 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $651,420 - $871,508	-1,100 Reduced 5.08%	20,560 $16 Million
Q4 2023 Feb 02, 2024	SELL	$525.19 - $619.13 $472,671 - $557,217	-900 Reduced 3.99%	21,660 $12.6 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $825,930 - $1.14 Million	-1,900 Reduced 7.77%	22,560 $12.1 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $578,790 - $674,406	-1,800 Reduced 6.85%	24,460 $0
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $377,936 - $489,256	-2,300 Reduced 8.05%	26,260 $4.91 Million
Q3 2019 Oct 18, 2019	BUY	$106.79 - $116.16 $491,234 - $534,336	4,600 Added 19.2%	28,560 $3.19 Million
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $115,762 - $136,260	-1,040 Reduced 4.16%	23,960 $3.11 Million
Q4 2018 Jan 24, 2019	SELL	$105.9 - $118.64 $1.06 Million - $1.19 Million	-10,000 Reduced 28.57%	25,000 $2.89 Million
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $2.7 Million - $2.99 Million	35,000	35,000 $2.99 Million

Others Institutions Holding LLY

# of Institutions

4,475

Shares Held

779M

Call Options Held

16.9M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $878B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Account

Nj State Employees Deferred Compensation Plan Eli Lilly & CO Transaction History